https://doi.org/10.1530/erc-15-0245 · 
Повний текст
Видання: Endocrine-Related Cancer, 2015, №6, с.941-952
Видавець: Bioscientifica
Автори:
- Kathrin A Schmohl
- Andrea M Müller
- Alexandra Wechselberger
- Svenja Rühland
- Nicole Salb
- Nathalie Schwenk
- Heike Heuer
- Janette Carlsen
- Burkhard Göke
- Peter J Nelson
- Christine Spitzweg
Анотація
To improve our understanding of non-genomic, integrin αvβ3-mediated thyroid hormone action in tumour stroma formation, we examined the effects of triiodo-<jats:sc>l</jats:sc>-thyronine (T<jats:sub>3</jats:sub>),<jats:sc>l</jats:sc>-thyroxine (T<jats:sub>4</jats:sub>) and integrin-specific inhibitor tetrac on differentiation, migration and invasion of mesenchymal stem cells (MSCs) that are an integral part of the tumour's fibrovascular network. Primary human bone marrow-derived MSCs were treated with T<jats:sub>3</jats:sub>or T<jats:sub>4</jats:sub>in the presence of hepatocellular carcinoma (HCC) cell-conditioned medium (CM), which resulted in stimulation of the expression of genes associated with cancer-associated fibroblast-like differentiation as determined by qPCR and ELISA. In addition, T<jats:sub>3</jats:sub>and T<jats:sub>4</jats:sub>increased migration of MSCs towards HCC cell-CM and invasion into the centre of three-dimensional HCC cell spheroids. All these effects were tetrac-dependent and therefore integrin αvβ3-mediated. In a subcutaneous HCC xenograft model, MSCs showed significantly increased recruitment and invasion into tumours of hyperthyroid mice compared to euthyroid and, in particular, hypothyroid mice, while treatment with tetrac almost completely eliminated MSC recruitment. These studies significantly improve our understanding of the anti-tumour activity of tetrac, as well as the mechanisms that regulate MSC differentiation and recruitment in the context of tumour stroma formation, as an important prerequisite for the utilisation of MSCs as gene delivery vehicles.
Список літератури
- Balzan S Del Carratore R Nardulli C Sabatino L Lubrano V Iervasi G 2013 The stimulative effect of T3 and T4 on human myocardial endothelial cell proliferation, migration and angiogenesis. Journal of Clinical & Experimental Cardiology 04 1–7. (doi:10.4172.2125-9880.1000280).
https://doi.org/10.4172/2155-9880.1000280 - Barcellos-de-Souza P Gori V Bambi F Chiarugi P 2013 Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochimica et Biophysica Acta 1836 321–335. (doi:10.1016/j.bbca.2013.10.004).
- Davis PJ Lin HY Sudha T Yalcin M Tang HY Hercbergs A Leith JT Luidens MK Ashur-Fabian O Incerpi S 2014 Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis. OncoTargets and Therapy 7 1619–1624. (doi:10.2147/OTT.S67393).
https://doi.org/10.2147/OTT.S67393 - Edelstein A Amodaj N Hoover K Vale R Stuurman N 2010 Computer control of microscopes using microManager. Current Protocols in Molecular Biology 92 Unit 14.20 14.20.1–14.20.17 doi:10.1002/0471142727.mb1420s92).
- Hercbergs AH Davis FB Lin H-Y Luidens MK Meng R Ashur-Fabian O Mousa SA Davis PJ 2012 Integrin-mediated actions of thyroid hormone analogues on tumor cell chemosensitivity, integrin-growth factor receptor crosstalk and inflammatory gene expression. Cancer and Clinical Oncology 1 32–40. (doi:10.5539/cco.v1n1p32).
https://doi.org/10.5539/cco.v1n1p32 - Kholodenko IV Konieva AA Kholodenko RV Yarygin KN 2013 Molecular mechanisms of migration and homing of intravenously transplanted mesenchymal stem cells. Journal of Tissue Engineering and Regenerative Medicine 2 2. (doi:10.7243/2050-1218-2-4).
https://doi.org/10.7243/2050-1218-2-4 - Yalcin M Bharali DJ Lansing L Dyskin E Mousa SS Hercbergs A Davis FB Davis PJ Mousa SA 2009 Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts. Anticancer Research 29 3825–3831.
- Zhu Y Cheng M Yang Z Zeng CY Chen J Xie Y Luo SW Zhang KH Zhou SF Lu NH 2014 Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts. Drug Design, Development and Therapy 8 2449–2462. (doi:10.2147/DDDT.S71466).
https://doi.org/10.2147/DDDT.S71466
Публікації, які цитують цю публікацію
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy
Carolin Kitzberger, Rebekka Spellerberg, Volker Morath, Nathalie Schwenk, Kathrin A. Schmohl, Christina Schug, Sarah Urnauer, Mariella Tutter, Matthias Eiber, Franz Schilling, Wolfgang A. Weber, Sibylle Ziegler, Peter Bartenstein, Ernst Wagner, Peter J. Nelson, Christine Spitzweg
https://doi.org/10.1186/s13550-022-00888-w ·
2022, EJNMMI Research, №1
Scopus
WoS
Цитувань Crossref:1
Nongenomic Actions of Thyroid Hormones
Sandra Incerpi, Paul J. Davis, Jens Z. Pedersen, Antonia Lanni
https://doi.org/10.1007/978-3-319-27318-1_32-1
2016, Endocrinology Principles of Endocrinology and Hormone Action, с.1-26
Scopus
Цитувань Crossref:0
A Two-Stage Mendelian Randomization Analysis of Million-Scale Data Reveals Thyroid Dysfunction Casually Associated with Increased Lung Cancer Risk Among Smokers
Lijuan Lin, Xiang Wang, Zoucheng Pan, Hui Huang, Yue Jiang, Jiajin Chen, Sipeng Shen, Yang Zhao, Yongyue Wei, Ruyang Zhang, Feng Chen
https://doi.org/10.2139/ssrn.4184813
2022, SSRN Electronic Journal
Цитувань Crossref:0
A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery
Christina Schug, Aayush Gupta, Sarah Urnauer, Katja Steiger, Phyllis Fung-Yi Cheung, Christian Neander, Konstantinos Savvatakis, Kathrin A. Schmohl, Marija Trajkovic-Arsic, Nathalie Schwenk, Markus Schwaiger, Peter J. Nelson, Jens T. Siveke, Christine Spitzweg
https://doi.org/10.1158/1541-7786.mcr-18-0185
2019, Molecular Cancer Research, №1, с.310-320
Scopus
WoS
Цитувань Crossref:10
Tetrac as an anti-angiogenic agent in cancer
Kathrin A Schmohl, Peter J Nelson, Christine Spitzweg
https://doi.org/10.1530/erc-19-0058 · Повний текст
2019, Endocrine-Related Cancer, №6, с.R287-R304
Scopus
WoS
Цитувань Crossref:9
The Colorful Diversity of Thyroid Hormone Metabolites
Josef Köhrle
https://doi.org/10.1159/000497141 ·
2019, European Thyroid Journal, №3, с.115-129
Scopus
WoS
Цитувань Crossref:26
Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells
María Celeste Díaz Flaqué, Maria Florencia Cayrol, Helena Andrea Sterle, María del Rosario Aschero, Johanna Abigail Díaz Albuja, Blanca Isse, Ricardo Norberto Farías, Leandro Cerchietti, Cinthia Rosemblit, Graciela Alicia Cremaschi
https://doi.org/10.18632/oncotarget.26890 · Повний текст
2019, Oncotarget, №32, с.3051-3065
Scopus
Цитувань Crossref:5
Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer
André Wendindondé Nana, Yu-Tang Chin, Chi-Yu Lin, Yih Ho, James A Bennett, Ya-Jung Shih, Yi-Ru Chen, Chun A Changou, Jens Z Pedersen, Sandra Incerpi, Leroy F Liu, Jacqueline Whang-Peng, Earl Fu, Wen-Shan Li, Shaker A Mousa, Hung-Yun Lin, Paul J Davis
https://doi.org/10.1530/erc-17-0450 · Повний текст
2018, Endocrine-Related Cancer, №3, с.279-293
Scopus
WoS
Цитувань Crossref:19
The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer
Fabio Gionfra, Paolo De Vito, Valentina Pallottini, Hung-Yun Lin, Paul J. Davis, Jens Z. Pedersen, Sandra Incerpi
https://doi.org/10.3389/fendo.2019.00532 · Повний текст
2019, Frontiers in Endocrinology
Scopus
WoS
Цитувань Crossref:4
Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells
Shan-Jen Lin, Yu-Tang Chin, Yih Ho, Szu-Yi Chou, Yu-Chen Sh Yang, André Wendindondé Nana, Kuan-Wei Su, Yee-Tong Lim, Kuan Wang, Sheng‐Yang Lee, Ya-Jung Shih, Yi-Ru Chen, Jacqueline Whang-Peng, Paul J. Davis, Hung-Yun Lin, Earl Fu
https://doi.org/10.1016/j.fct.2018.06.058 ·
2018, Food and Chemical Toxicology, с.1-11
Scopus
WoS
Цитувань Crossref:15
Знайти всі цитування публікації
